Cell theraputics are therapies in which cellular material is injected, grafted or implanted into a patient, mostly intact, living cells. For example, T cells capable of fighting cancer cells via cell-mediated immunity may be injected in the course of immunotherapy.
The “Cell Theraputics Industry Forecast” looks at past sales and reviews total world Cell Theraputics sales in 2022, providing a comprehensive analysis by region and market sector of projected Cell Theraputics sales for 2023 through 2029. With Cell Theraputics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Theraputics industry.
This Insight Report provides a comprehensive analysis of the global Cell Theraputics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cell Theraputics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Theraputics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Theraputics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Theraputics.
The global Cell Theraputics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cell Theraputics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cell Theraputics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cell Theraputics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cell Theraputics players cover Bristol-Myers Squibb Company (Celgene), Bluebird Bio, Crispr Therapeutics, Roche (Spark Therapeutics), PTC Therapeutics, Moderna Therapeutics, Quanterix, Brainstorm Cell Therapeutics Inc. and Lineage Cell Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell Theraputics market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Stem Cells
Immunocyte
Segmentation by application
Allogeneic Cell Therapy
Autologous Cell Therapy
Xenogeneic Cell Therapy
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bristol-Myers Squibb Company (Celgene)
Bluebird Bio
Crispr Therapeutics
Roche (Spark Therapeutics)
PTC Therapeutics
Moderna Therapeutics
Quanterix
Brainstorm Cell Therapeutics Inc.
Lineage Cell Therapeutics
Cti Biopharma
Atara Biotherapeutics, Inc
Adaptimmune
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cell Theraputics Market Size 2018-2029
2.1.2 Cell Theraputics Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Cell Theraputics Segment by Type
2.2.1 Stem Cells
2.2.2 Immunocyte
2.3 Cell Theraputics Market Size by Type
2.3.1 Cell Theraputics Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Cell Theraputics Market Size Market Share by Type (2018-2023)
2.4 Cell Theraputics Segment by Application
2.4.1 Allogeneic Cell Therapy
2.4.2 Autologous Cell Therapy
2.4.3 Xenogeneic Cell Therapy
2.5 Cell Theraputics Market Size by Application
2.5.1 Cell Theraputics Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Cell Theraputics Market Size Market Share by Application (2018-2023)
3 Cell Theraputics Market Size by Player
3.1 Cell Theraputics Market Size Market Share by Players
3.1.1 Global Cell Theraputics Revenue by Players (2018-2023)
3.1.2 Global Cell Theraputics Revenue Market Share by Players (2018-2023)
3.2 Global Cell Theraputics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cell Theraputics by Regions
4.1 Cell Theraputics Market Size by Regions (2018-2023)
4.2 Americas Cell Theraputics Market Size Growth (2018-2023)
4.3 APAC Cell Theraputics Market Size Growth (2018-2023)
4.4 Europe Cell Theraputics Market Size Growth (2018-2023)
4.5 Middle East & Africa Cell Theraputics Market Size Growth (2018-2023)
5 Americas
5.1 Americas Cell Theraputics Market Size by Country (2018-2023)
5.2 Americas Cell Theraputics Market Size by Type (2018-2023)
5.3 Americas Cell Theraputics Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell Theraputics Market Size by Region (2018-2023)
6.2 APAC Cell Theraputics Market Size by Type (2018-2023)
6.3 APAC Cell Theraputics Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cell Theraputics by Country (2018-2023)
7.2 Europe Cell Theraputics Market Size by Type (2018-2023)
7.3 Europe Cell Theraputics Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cell Theraputics by Region (2018-2023)
8.2 Middle East & Africa Cell Theraputics Market Size by Type (2018-2023)
8.3 Middle East & Africa Cell Theraputics Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Cell Theraputics Market Forecast
10.1 Global Cell Theraputics Forecast by Regions (2024-2029)
10.1.1 Global Cell Theraputics Forecast by Regions (2024-2029)
10.1.2 Americas Cell Theraputics Forecast
10.1.3 APAC Cell Theraputics Forecast
10.1.4 Europe Cell Theraputics Forecast
10.1.5 Middle East & Africa Cell Theraputics Forecast
10.2 Americas Cell Theraputics Forecast by Country (2024-2029)
10.2.1 United States Cell Theraputics Market Forecast
10.2.2 Canada Cell Theraputics Market Forecast
10.2.3 Mexico Cell Theraputics Market Forecast
10.2.4 Brazil Cell Theraputics Market Forecast
10.3 APAC Cell Theraputics Forecast by Region (2024-2029)
10.3.1 China Cell Theraputics Market Forecast
10.3.2 Japan Cell Theraputics Market Forecast
10.3.3 Korea Cell Theraputics Market Forecast
10.3.4 Southeast Asia Cell Theraputics Market Forecast
10.3.5 India Cell Theraputics Market Forecast
10.3.6 Australia Cell Theraputics Market Forecast
10.4 Europe Cell Theraputics Forecast by Country (2024-2029)
10.4.1 Germany Cell Theraputics Market Forecast
10.4.2 France Cell Theraputics Market Forecast
10.4.3 UK Cell Theraputics Market Forecast
10.4.4 Italy Cell Theraputics Market Forecast
10.4.5 Russia Cell Theraputics Market Forecast
10.5 Middle East & Africa Cell Theraputics Forecast by Region (2024-2029)
10.5.1 Egypt Cell Theraputics Market Forecast
10.5.2 South Africa Cell Theraputics Market Forecast
10.5.3 Israel Cell Theraputics Market Forecast
10.5.4 Turkey Cell Theraputics Market Forecast
10.5.5 GCC Countries Cell Theraputics Market Forecast
10.6 Global Cell Theraputics Forecast by Type (2024-2029)
10.7 Global Cell Theraputics Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Bristol-Myers Squibb Company (Celgene)
11.1.1 Bristol-Myers Squibb Company (Celgene) Company Information
11.1.2 Bristol-Myers Squibb Company (Celgene) Cell Theraputics Product Offered
11.1.3 Bristol-Myers Squibb Company (Celgene) Cell Theraputics Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Bristol-Myers Squibb Company (Celgene) Main Business Overview
11.1.5 Bristol-Myers Squibb Company (Celgene) Latest Developments
11.2 Bluebird Bio
11.2.1 Bluebird Bio Company Information
11.2.2 Bluebird Bio Cell Theraputics Product Offered
11.2.3 Bluebird Bio Cell Theraputics Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Bluebird Bio Main Business Overview
11.2.5 Bluebird Bio Latest Developments
11.3 Crispr Therapeutics
11.3.1 Crispr Therapeutics Company Information
11.3.2 Crispr Therapeutics Cell Theraputics Product Offered
11.3.3 Crispr Therapeutics Cell Theraputics Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Crispr Therapeutics Main Business Overview
11.3.5 Crispr Therapeutics Latest Developments
11.4 Roche (Spark Therapeutics)
11.4.1 Roche (Spark Therapeutics) Company Information
11.4.2 Roche (Spark Therapeutics) Cell Theraputics Product Offered
11.4.3 Roche (Spark Therapeutics) Cell Theraputics Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Roche (Spark Therapeutics) Main Business Overview
11.4.5 Roche (Spark Therapeutics) Latest Developments
11.5 PTC Therapeutics
11.5.1 PTC Therapeutics Company Information
11.5.2 PTC Therapeutics Cell Theraputics Product Offered
11.5.3 PTC Therapeutics Cell Theraputics Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 PTC Therapeutics Main Business Overview
11.5.5 PTC Therapeutics Latest Developments
11.6 Moderna Therapeutics
11.6.1 Moderna Therapeutics Company Information
11.6.2 Moderna Therapeutics Cell Theraputics Product Offered
11.6.3 Moderna Therapeutics Cell Theraputics Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Moderna Therapeutics Main Business Overview
11.6.5 Moderna Therapeutics Latest Developments
11.7 Quanterix
11.7.1 Quanterix Company Information
11.7.2 Quanterix Cell Theraputics Product Offered
11.7.3 Quanterix Cell Theraputics Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Quanterix Main Business Overview
11.7.5 Quanterix Latest Developments
11.8 Brainstorm Cell Therapeutics Inc.
11.8.1 Brainstorm Cell Therapeutics Inc. Company Information
11.8.2 Brainstorm Cell Therapeutics Inc. Cell Theraputics Product Offered
11.8.3 Brainstorm Cell Therapeutics Inc. Cell Theraputics Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Brainstorm Cell Therapeutics Inc. Main Business Overview
11.8.5 Brainstorm Cell Therapeutics Inc. Latest Developments
11.9 Lineage Cell Therapeutics
11.9.1 Lineage Cell Therapeutics Company Information
11.9.2 Lineage Cell Therapeutics Cell Theraputics Product Offered
11.9.3 Lineage Cell Therapeutics Cell Theraputics Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Lineage Cell Therapeutics Main Business Overview
11.9.5 Lineage Cell Therapeutics Latest Developments
11.10 Cti Biopharma
11.10.1 Cti Biopharma Company Information
11.10.2 Cti Biopharma Cell Theraputics Product Offered
11.10.3 Cti Biopharma Cell Theraputics Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Cti Biopharma Main Business Overview
11.10.5 Cti Biopharma Latest Developments
11.11 Atara Biotherapeutics, Inc
11.11.1 Atara Biotherapeutics, Inc Company Information
11.11.2 Atara Biotherapeutics, Inc Cell Theraputics Product Offered
11.11.3 Atara Biotherapeutics, Inc Cell Theraputics Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Atara Biotherapeutics, Inc Main Business Overview
11.11.5 Atara Biotherapeutics, Inc Latest Developments
11.12 Adaptimmune
11.12.1 Adaptimmune Company Information
11.12.2 Adaptimmune Cell Theraputics Product Offered
11.12.3 Adaptimmune Cell Theraputics Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Adaptimmune Main Business Overview
11.12.5 Adaptimmune Latest Developments
12 Research Findings and Conclusion
*If Applicable.